ArticlePLoS computational biology2026
Multiscale modeling of T cell exhaustion: A mathematical framework integrating continuous dynamics with spatial heterogeneity.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Continuous antigen exposure drives T cells into a progressive state of dysfunction known as exhaustion, enabling tumors to evade immune surveillance and promoting disease progression. Despite its importance, predictive modeling of T cell exhaustion remains a major challenge due to the complexity of its regulatory dynamics. To address this challenge, we developed a mathematical framework that characterizes the dynamic regulation of T cell exhaustion and its impact on tumor-immune interactions. Here, we integrate multi-source data, population dynamics modeling, and agent-based modeling to track the progressive stages of CD8+ T cell exhaustion. Our model demonstrates that immune checkpoint blockade significantly delays exhaustion and promotes the expansion of tumor-reactive T cells compared to untreated conditions. From a pseudo-potential energy perspective, we show that the core mechanism of immunotherapy lies in expanding the tumor-reactive T cell pool, which consequently reduces the overall state of exhaustion within the system. We find that T cell activation and exhaustion signals jointly govern tumor-immune dynamics. Enhancing activation alone without restricting exhaustion can inadvertently accelerate the loss of T cell function. In contrast, combining enhanced activation (via anti-CTLA-4) with suppressed exhaustion (via anti-PD-1) is essential for achieving a sustained antitumor response. Furthermore, spatial simulations confirm that a high-activation and low-exhaustion state effectively restricts tumor spread, maintaining substantially lower tumor densities compared to low-activation, high-exhaustion scenarios. Our framework provides quantitative insights into T cell exhaustion and a theoretical foundation for optimizing combination immunotherapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.